LEIGHA BOWYER JONES: Open Payments
NPI 1710483037 · JEFFERSONVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$346 in 18 payments from 11 companies in 2025. Trend: 2023 $419 · 2024 $310 · 2025 $346
Food & beverage: $346
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $58 |
| Lundbeck LLC | 2 | $50 |
| Neurocrine BioSciences, Inc. | 3 | $49 |
| Janssen Pharmaceuticals, Inc | 2 | $44 |
| Vanda Pharmaceuticals Inc. | 2 | $29 |
| Novo Nordisk Inc | 1 | $22 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $21 |
| Alkermes, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
Products named: CAPLYTA, INGREZZA, INVEGA SUSTENNA, ABILIFY ASIMTUFII, REXULTI, Rybelsus, Quviviq, ARISTADA.
Industry payments across IN — which companies pay providers there.
